FDA’s Office of Pharmaceutical Quality Revs Up Process to Accelerate ANDA Reviews

In a preview of how the FDA’s Office of Pharmaceutical Quality will speed approval of generic drugs, the office is rolling out a framework for ANDA filers to respond to minor agency queries involving chemistry, manufacturing and control issues early in the review cycle.
Generic Line